The Patent Cooperation Treaty (PCT) is an international treaty administered by the World Intellectual Property Organization (WIPO) that simplifies the process of seeking patent protection for inventions in multiple countries. The PCT does not grant an "international patent." Instead, it provides a unified international filing procedure through which an applicant can preserve the possibility of obtaining patents in multiple countries, followed by examination and grant by individual national or regional patent offices.
For Indian corporates developing technology for international markets, the PCT is an important tool for managing patent portfolios, controlling costs, assessing patentability and deciding where international patent protection is commercially justified.
1. What is the PCT?
PCT stands for Patent Cooperation Treaty. It enables an applicant to file one international patent application rather than immediately filing separate applications in every desired country.
An Indian company can broadly follow this route:
Indian priority application PCT application International Search Written Opinion International publication National/regional phase Country-specific examination Patent grant/refusal.
The PCT currently has 159 Contracting States. A PCT application can preserve the applicant's ability to seek protection in these jurisdictions, subject to the applicable national laws and deadlines.
The PCT therefore provides a common international filing and prosecution framework, but patent rights ultimately remain territorial.
2. What the PCT Does and Does Not Do
The PCT provides:
- A single international filing procedure.
- An international filing date.
- Priority preservation.
- International prior-art searching.
- A written opinion on patentability.
- International publication.
- Additional time to decide where to seek patent protection.
- Deferral of many national-phase expenses.
- A structured route into national/regional patent systems.
The PCT does not:
- Grant a worldwide patent.
- Guarantee that a patent will be granted.
- Eliminate national patent laws.
- Eliminate national-phase fees.
- Eliminate foreign patent-agent costs.
- Provide freedom to operate.
- Replace national patent examination.
- Provide worldwide enforcement rights.
The ultimate decision to grant a patent remains with the relevant national or regional patent office.
3. Why is PCT Important for Indian Corporates?
Indian companies increasingly develop products and technologies for global markets. Examples include:
- Artificial intelligence and technology;
- Pharmaceuticals;
- Biotechnology;
- Medical devices;
- Electronics and semiconductors;
- Automotive technology;
- Renewable energy;
- Telecommunications;
- Industrial machinery;
- Advanced materials;
- Software-related technical inventions.
A company may not know at the time of its first patent filing which foreign markets will eventually justify the cost of patent protection.
The PCT provides additional time to evaluate:
- Market potential;
- Competitors;
- Patentability;
- Customer demand;
- Investment;
- Licensing opportunities;
- Manufacturing locations;
- Commercial success;
- Cost of protection in different jurisdictions.
This makes PCT filing an important business and IP strategy tool, not merely a legal filing mechanism.
4. Basic PCT Timeline
Suppose an Indian company files its first patent application on 1 October 2026.
Priority period - 12 months
Generally, the PCT application claiming priority from that first application should be filed within 12 months, i.e. by 1 October 2027.
International publication - approximately 18 months
The PCT application is generally published approximately 18 months from the earliest priority date.
National/regional phase - generally around 30 months
The applicant generally has approximately 30 months from the priority date to enter the national or regional phase in the relevant jurisdictions, although specific national deadlines must always be checked.
This gives the company additional time to decide where it actually wants patent protection.
5. Filing a PCT Application from India
An Indian company can use the Indian Patent Office as a PCT Receiving Office. PCT applications can also be filed electronically through the applicable WIPO/ePCT systems.
A PCT application generally contains:
- Request;
- Description;
- Claims;
- Abstract;
- Drawings, where applicable;
- Priority information;
- Applicant and inventor details;
- Other prescribed information and documents;
- Applicable fees.
Before filing, the company should verify ownership, inventor details, priority dates, confidentiality and the countries in which protection may ultimately be required.
6. Section 39 of the Indian Patents Act
For Indian residents, Section 39 of the Patents Act, 1970 is a critical consideration.
An Indian resident generally cannot make a foreign patent application for an invention without satisfying the requirements of Section 39. Depending on the circumstances, this may involve:
- Filing the application first in India and observing the prescribed period; or
- Obtaining prior permission from the Controller before making the foreign filing.
Where prior permission is required, the relevant application is made using Form 25.
Indian corporates should therefore make Section 39 compliance a mandatory checkpoint before filing a PCT application or other foreign patent application.
This is particularly important where the invention was developed in India and the relevant inventors/applicants are Indian residents.
7. International Search
One of the most valuable PCT features is the International Search.
An International Searching Authority (ISA) conducts a search for relevant prior art. The applicant generally receives:
- International Search Report (ISR); and
- Written Opinion of the International Searching Authority.
These documents provide information concerning prior art and the apparent patentability of the claimed invention.
For a corporate applicant, this information can help answer:
- Is the invention novel?
- Are there potentially relevant earlier patents?
- Is inventive step likely to be challenged?
- Should claims be amended?
- Is international protection commercially justified?
- Which countries should be selected?
- Should the company license, abandon or further develop the technology?
The international search and written opinion are valuable decision-making tools, although they are not binding on national patent offices.
8. International Searching Authorities for Indian Applicants
Indian PCT applicants may have access to various competent International Searching Authorities, subject to the applicable PCT rules and current arrangements. These can include authorities such as:
- Indian Patent Office;
- European Patent Office;
- United States Patent and Trademark Office;
- Japan Patent Office;
- China National Intellectual Property Administration;
- Australian Patent Office;
- Austrian Patent Office;
- Swedish Intellectual Property Office.
The applicable authority and fee should be verified when filing.
9. International Publication
The PCT application is generally published approximately 18 months from the priority date.
Publication makes the application and relevant documents publicly available through WIPO's PATENTSCOPE system.
This means companies must carefully consider patent filing strategy before publicly disclosing their technology.
An invention should ideally be evaluated for patent protection before:
- Product launch;
- Public demonstration;
- Conference presentation;
- Publication;
- Website disclosure;
- Technical paper;
- Uncontrolled investor presentation;
- Customer disclosure.
Public disclosure can have serious consequences for patentability in many jurisdictions.
10. Article 19 Amendments
After receiving the international search report, the applicant has an opportunity under the PCT system to amend the claims.
A company may use the search results to:
- Narrow claims;
- Clarify claim language;
- Address prior-art concerns;
- Improve claim structure;
- Protect commercially important features.
Any amendment must comply with the applicable PCT requirements and must not improperly introduce new subject matter.
11. International Preliminary Examination
The PCT also provides an optional international preliminary examination procedure.
This can provide further analysis concerning:
- Novelty;
- Inventive step/non-obviousness;
- Industrial applicability.
For a corporate applicant, this additional assessment may help in deciding whether the invention merits expensive national-phase prosecution.
The resulting report is informative and is not binding on national patent offices.
12. National/Regional Phase
This is the stage at which the applicant seeks actual patent protection.
For example, an Indian company may decide to enter:
- United States;
- European regional system;
- China;
- Japan;
- Australia;
- Canada;
- India;
depending on commercial requirements.
Each relevant patent office then examines the application under its own national or regional law.
Therefore:
PCT Application = International Patent
The correct concept is:
- PCT Application International Phase National/Regional Phase Individual Patent Rights
A company ultimately receives enforceable patent rights only in jurisdictions where the relevant patent office grants a patent.
13. Major Financial Benefit
The PCT does not make international patent protection inexpensive. Its major financial advantage is that it can defer and rationalise expenditure.
Direct foreign filing can require early payment of:
- Foreign official fees;
- Patent-agent fees;
- Translation costs;
- Filing expenses;
- Examination fees.
With a PCT strategy, the company can postpone many country-specific expenses until the national/regional phase. During the additional period, management can determine whether a particular market justifies further investment.
This is especially useful for Indian startups, SMEs and companies with limited international IP budgets.
14. PCT Fees for Indian Applicants
Fees change periodically, so companies should verify the applicable official fees immediately before filing.
The PCT Applicant's Guide currently identifies, for applications filed through the Indian Receiving Office, an international filing fee of approximately USD 1,667, plus an additional fee for sheets exceeding the prescribed number, with applicable electronic-filing reductions.
The Indian Patent Office's PCT information also provides an international search fee for searches conducted by the Indian ISA, with concessional amounts for eligible applicants such as natural persons, startups, small entities and educational institutions.
These are only official fees. Total international patent expenditure can also include:
- Patent-agent fees;
- Drafting costs;
- Translation;
- Search/examination costs;
- National-phase fees;
- Foreign-agent fees;
- Maintenance fees;
- Prosecution expenses.
15. PCT for Indian Startups
The PCT can be particularly useful for Indian startups because it provides time to determine whether an invention has sufficient commercial value to justify foreign protection.
A startup may use the PCT period to:
- Develop the product;
- Obtain investment;
- Test the market;
- Identify customers;
- Negotiate licences;
- Evaluate competitors;
- Assess patentability;
- Select important countries.
A PCT application can form part of an investor-facing IP portfolio, although investors will generally examine the quality, ownership and commercial relevance of the underlying patent rights rather than merely the existence of a PCT filing.
16. PCT and Investors
During investment, acquisition or due diligence, investors may examine:
- Ownership of inventions;
- Inventor assignments;
- Priority dates;
- PCT filing dates;
- Section 39 compliance;
- National-phase filings;
- Patent claims;
- Patentability;
- Third-party patents;
- Licensing arrangements;
- Renewal status;
- Pending objections.
Therefore, a corporate PCT strategy should be integrated with the company's broader legal and governance framework.
17. PCT and Licensing
A PCT application may also support international licensing.
For example, an Indian company developing a new industrial technology may identify potential licensees in Europe, Japan and the United States.
The PCT can preserve the company's ability to pursue patent protection in those markets while commercial negotiations take place.
However, licensing value depends on factors such as:
- Strength of claims;
- Patentability;
- Market size;
- Competitive technology;
- Remaining patent term;
- Ability to enforce the eventual patents.
A PCT application alone does not guarantee commercial licensing value.
18. PCT Does Not Equal Freedom to Operate
This is a crucial distinction.
Suppose an Indian company obtains a patent for an improved battery-management system. Another company may already hold a broader patent covering a particular battery architecture.
The Indian company's patent does not automatically give it the right to commercialise every implementation.
Therefore, corporations should conduct separate:
Patentability analysis + Freedom-to-Operate (FTO) analysis.
PCT prosecution primarily assists international patent filing and patentability assessment. It is not a substitute for FTO analysis.
19. PCT and Employee/Consultant Inventions
Before filing internationally, companies should confirm:
- Who invented the technology?
- Who owns the invention?
- Were employees involved?
- Were consultants involved?
- Were universities or research institutions involved?
- Were government funds used?
- Are assignments properly executed?
- Are joint applicants involved?
A PCT filing cannot cure an underlying ownership defect.
Corporate IP policies should therefore require proper invention disclosures and IP assignments before international filing.
20. PCT and Corporate Patent Portfolio Management
Not every invention requires the same international protection.
A company can classify inventions into:
Core inventions
Technology central to the company's competitive advantage.
Strategy: Consider broad international protection in commercially important jurisdictions.
Supporting inventions
Technology supporting a product but having less independent commercial value.
Strategy: Selective country protection.
Experimental inventions
Technology with uncertain commercial prospects.
Strategy: PCT filing may provide time to assess market potential before major national expenditure.
Licensing inventions
Technology primarily intended for licensing.
Strategy: Consider protection in jurisdictions relevant to potential licensees and markets.
This approach helps align patent expenditure with business objectives.
21. PCT for Different Indian Industries
Pharmaceuticals - PCT filing can support international protection for novel compounds, formulations, processes, delivery systems and other patentable innovations.
Biotechnology - International protection can be relevant where research and commercial markets span several countries.
Medical Devices - Protection may be required in multiple major healthcare markets.
Electronics and Semiconductors - International protection can be particularly important because development, manufacturing and sales may occur in different countries.
Renewable Energy - Battery, solar, hydrogen, energy-management and related technologies often have international commercial potential.
Automotive - Components, control systems, manufacturing technologies and technical innovations may require protection across major automotive markets.
AI and Software-Related Technology - Where the invention satisfies applicable patentability requirements, PCT filing may preserve international options for technical inventions.
22. PCT vs Direct Foreign Filing
Direct foreign filing
The applicant files individually in selected countries within the priority period.
Advantages:
- Direct entry into chosen countries.
- Appropriate where only a small number of countries are important.
Disadvantages:
- Multiple filings.
- Earlier costs.
- Multiple foreign attorneys.
- Earlier translation/prosecution expenses.
PCT filing
The applicant initially files one international application and later chooses national/regional jurisdictions.
Advantages:
- Centralised initial process.
- International search.
- More time for commercial evaluation.
- Deferred national-phase decisions.
- Better coordination of international strategy.
The appropriate approach depends on the invention, commercial markets, urgency, budget and corporate objectives.
23. Indian Patent vs PCT
An Indian patent and PCT application serve different purposes.
| Indian Patent | PCT |
| Protection under Indian patent law | International filing route |
| Territorial Indian rights | Preserves international filing options |
| Indian examination | International search plus later national examination |
| Appropriate for Indian protection | Appropriate where foreign protection is contemplated |
| Indian prosecution | International phase followed by national/regional prosecution |
If a company only requires protection in India, a PCT filing may not be necessary. If the company expects substantial foreign commercial activity, the PCT can be an important component of its international patent strategy.
24. Recommended PCT Workflow for Indian Corporates
A corporate IP department can adopt the following procedure:
1. Invention disclosure Employee/research team submits technical disclosure.
2. Preliminary IP assessment Assess novelty, inventive step, commercial importance and potential markets.
3. Confidentiality review Ensure there has been no problematic public disclosure.
4. Ownership review Confirm inventors, assignments and corporate ownership.
5. Indian priority filing File the initial Indian patent application where appropriate.
6. International strategy During the 12-month priority period, assess PCT requirements.
7. Section 39 compliance Verify whether foreign-filing permission is required.
8. PCT filing File the international application within the priority period.
9. International search Review the ISR and written opinion.
10. Claim strategy Consider amendments and further examination where appropriate.
11. Commercial assessment Review market potential, competitors, licensing and investment.
12. National-phase decision Select countries based on commercial and legal importance.
13. National/regional filings Enter selected jurisdictions within the applicable deadline.
14. Portfolio management Monitor prosecution, grants, renewals, assignments, licences and enforcement.
25. Principal Benefits for Indian Corporates
| PCT Benefit | Corporate Importance |
| Single international application | Simplifies initial international filing |
| Priority preservation | Protects foreign filing options |
| International search | Identifies relevant prior art |
| Written opinion | Provides early patentability information |
| Additional decision time | Allows commercial assessment |
| Deferred national expenses | Improves cash-flow planning |
| International publication | Creates an international patent record |
| Centralised administration | Reduces initial procedural complexity |
| Country selection later | Allows investment to follow market opportunity |
| Support for licensing | Can strengthen international IP strategy |
26. Limitations and Risks
Corporates should also recognise that:
- A PCT application does not guarantee patent grant.
- National patent offices can reach different conclusions.
- National-phase costs can be substantial.
- Foreign patent attorneys may still be required.
- Translations may be necessary.
- Deadlines must be carefully monitored.
- The PCT does not provide worldwide enforcement.
- A PCT filing does not provide freedom to operate.
- A company ultimately has to decide where it wants actual patent rights.
Therefore, PCT filing should be treated as part of a broader IP strategy rather than as the complete patent-protection solution.
27. Corporate IP Policy
A mature Indian corporate IP policy should include:
- Mandatory invention disclosure.
- Confidentiality controls.
- Inventor identification.
- IP assignment procedures.
- Patentability assessment.
- Indian priority filing.
- PCT decision within the 12-month priority period.
- Section 39 compliance.
- International search review.
- National-phase selection criteria.
- Patent budget approval.
- Foreign-agent management.
- Renewal/annuity tracking.
- Freedom-to-operate analysis.
- Licensing strategy.
- Enforcement strategy.
- Regular IP portfolio review.
Conclusion
For Indian corporates, the PCT is a strategic bridge between Indian innovation and international patent protection. It allows an Indian company to make a single international application, obtain an international search and written opinion, and gain additional time to determine which foreign markets justify the cost of patent protection.
The central strategy is:
Innovation Confidentiality Indian priority filing PCT within 12 months International Search Written Opinion Commercial/IP evaluation National-phase selection Country-specific prosecution Patent grant and enforcement.
Its greatest corporate value lies in flexibility, information and deferred decision-making. A company can preserve international patent options while it evaluates market demand, competitors, investment, licensing opportunities and the commercial importance of the invention.
However, the PCT should never be misunderstood as an international patent. Actual patent rights arise only through the relevant national or regional patent systems.
For Indian companies seeking to commercialise technology internationally, an effective PCT strategy should therefore be integrated with patentability analysis, Section 39 compliance, ownership documentation, freedom-to-operate analysis, licensing, investment due diligence, national-phase budgeting and long-term patent portfolio management.
Official References
- WIPO - PCT System: https://www.wipo.int/en/web/pct-system
- WIPO - PCT Applicant's Guide: https://www.wipo.int/en/web/pct-system/guide
- IP India - PCT/ISA/IPEA: https://www.ipindia.gov.in/pages/patents/pct-isa-ipea
- IP India - Section 39: https://ipindia.gov.in/acts/patent-act-1970/section-39
- WIPO - National Phase: https://www.wipo.int/en/web/pct-system/national-phase
Fees, deadlines and national-phase requirements can change. The applicable WIPO and Indian Patent Office rules should be verified at the time of filing, particularly for Section 39 compliance and national-phase deadlines.
***
TaxTMI